HRV Chart for Females by Age
Sex-stratified studies find age-related HRV differences, but the direction and size depend on the metric and protocol. The broad bands below are illustrative values assembled from heterogeneous studies, not validated female-specific diagnostic intervals.
Reference Data
| Age Range | Illustrative RMSSD span (ms) | Illustrative SDNN span (ms) |
|---|---|---|
| 20–25 | 24–100(24–100) | 36–112(36–112) |
| 25–30 | 22–92(22–92) | 34–108(34–108) |
| 30–35 | 19–82(19–82) | 32–102(32–102) |
| 35–40 | 16–74(16–74) | 29–96(29–96) |
| 40–45 | 14–66(14–66) | 27–90(27–90) |
| 45–50 | 12–58(12–58) | 25–85(25–85) |
| 50–55 | 10–50(10–50) | 22–80(22–80) |
| 55–60 | 9–44(9–44) | 20–75(20–75) |
| 60–65 | 8–40(8–40) | 18–70(18–70) |
| 65–70 | 7–36(7–36) | 16–66(16–66) |
| 70–75 | 6–32(6–32) | 14–62(14–62) |
| 75+ | 5–28(5–28) | 12–58(12–58) |
Source: van den Berg et al., Lifelines Cohort Study, 2020 (sex- and age-stratified 10-second ECG values): https://pmc.ncbi.nlm.nih.gov/articles/PMC7734556/ ; Koenig & Thayer, 2016: https://pubmed.ncbi.nlm.nih.gov/27598757/
How to Interpret This Data
Female HRV is influenced by unique physiological factors not present in males. During the menstrual cycle, HRV is typically highest in the follicular phase (days 1–14) when estrogen is dominant, and lowest during the luteal phase (days 15–28) when progesterone increases sympathetic tone. This cyclical variation can cause RMSSD to fluctuate by 10–20% within a single month, making it important to compare measurements taken at the same cycle phase.
Menopause is associated with a significant decline in HRV beyond what is expected from aging alone. The loss of estrogen's cardioprotective and vagotonic effects leads to an accelerated HRV decline typically beginning in the perimenopausal period (ages 45–55). Hormone replacement therapy has been shown in some studies to partially attenuate this decline, though the evidence remains mixed. Pregnancy also substantially alters HRV, with a progressive decrease in parasympathetic tone from the first to third trimester.
When interpreting female HRV, consider cycle phase, menopausal status, hormonal contraceptive use, and pregnancy status. Oral contraceptives can reduce HRV by suppressing the natural hormonal fluctuations that modulate vagal tone. These ranges represent general population norms for healthy females; individual targets should account for fitness level, body composition, and overall cardiovascular health. Consult a healthcare provider if HRV is persistently below the lower range for your age.
Frequently Asked Questions
Is HRV different for women compared to men?
Yes. Younger women (under 30) tend to have similar or slightly higher RMSSD values than men due to greater vagal tone, but SDNN values are typically slightly lower. After menopause, female HRV often declines more sharply than male HRV of the same age due to the loss of estrogen's cardioprotective effects. Menstrual cycle phase also creates cyclical HRV variations unique to premenopausal women.
Does the menstrual cycle affect HRV readings?
Cycle-related HRV differences have been reported, but their size and direction vary across studies and protocols. For trend tracking, compare readings collected under consistent conditions and consider cycle phase as one possible influence rather than applying a fixed percentage correction.
How does menopause affect heart rate variability?
HRV changes across midlife and menopause have been reported, but aging, symptoms, medication and cardiovascular risk factors complicate attribution to menopause itself. The cited evidence does not support a universal 15–25% RMSSD decrement for an individual.